Ipsen nelle notizie
Oncologia neuroscienze malattie rare
Tamtam ha trovato 18 articoli recenti su Ipsen.
- Rethinking discovery: how powerful screening tools are redefining the search for new medicines
- Ipsen: Stock Dips Below €140.50 Support Then Recovers Above Key Level
- Ipsen : l'action passe sous 140,50 € puis repasse au-dessus de son support
- Ipsen S.A. A (I7G.MU) Q2 FY2026 earnings call transcript
- When science advances, understanding must keep pace
- Famille Beaufour : les milliards cachés derrière Ipsen
- Ipsen SA at Deutsche Bank ADR Investor Conference (Virtual) Transcript
- Net current asset value per share of Ipsen SA – HAN:I7G
- Ipsen SA Earnings and Revenue – HAN:I7G
- Building more sustainable laboratories with My Green Lab
- IPSEN - Buy-back programme - Art 5 of MAR - Week 39 - 2026
- Point recommandations des analystes : Crédit Agricole SA, Bureau Veritas, Ipsen
- IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 39 - 2026
- About €147 per share was the average price in Ipsen's two-day buyback.
- Ipsen chute après l'approbation d'un générique du Somatuline aux USA
- Action Ipsen | Cours IPN Bourse Euronext Paris
- Ipsen perd 3,89%
- Ipsen (ENXTPA:IPN) Could Be 11% Undervalued Following Board Changes
Articoli raccolti da Tamtam e conservati quando riguardano l'azienda, dal più recente. Ognuno rimanda alla sua fonte.
Vendi ad aziende come Ipsen?
Tamtam trova le aziende in linea con il tuo cliente ideale, analizza ogni account e ti dice chi contattare e quando.
Trova aziende simili